Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B4ZQ
|
|||
Former ID |
DIB001411
|
|||
Drug Name |
SL-90.0571
|
|||
Indication | Epilepsy [ICD-11: 8A60-8A68] | Discontinued in Phase 1 | [1] | |
Company |
Synthelabo
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sodium channel unspecific (NaC) | Target Info | Modulator | [2] |
KEGG Pathway | Dopaminergic synapse | |||
Reactome | Interaction between L1 and Ankyrins |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002249) | |||
REF 2 | WO patent application no. 19990639849, Novel sodium channel drugs and uses. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.